Cargando…

Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies

Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Poljšak, Borut, Kovač, Vito, Milisav, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495723/
https://www.ncbi.nlm.nih.gov/pubmed/36139711
http://dx.doi.org/10.3390/antiox11091637
_version_ 1784794089278930944
author Poljšak, Borut
Kovač, Vito
Milisav, Irina
author_facet Poljšak, Borut
Kovač, Vito
Milisav, Irina
author_sort Poljšak, Borut
collection PubMed
description Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the interest in the use of NAD+ boosters as dietary supplements, both in scientific circles and among the general population. Here, we discuss the current trends in NAD+ precursor usage as well as the uncertainties in dosage, timing, safety, and side effects. There are many unknowns regarding pharmacokinetics and pharmacodynamics, particularly bioavailability, metabolism, and tissue specificity of NAD+ boosters. Given the lack of long-term safety studies, there is a need for more clinical trials to determine the proper dose of NAD+ boosters and treatment duration for aging prevention and as disease therapy. Further research will also need to address the long-term consequences of increased NAD+ and the best approaches and combinations to increase NAD+ levels. The answers to the above questions will contribute to the more efficient and safer use of NAD+ boosters.
format Online
Article
Text
id pubmed-9495723
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94957232022-09-23 Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies Poljšak, Borut Kovač, Vito Milisav, Irina Antioxidants (Basel) Review Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the interest in the use of NAD+ boosters as dietary supplements, both in scientific circles and among the general population. Here, we discuss the current trends in NAD+ precursor usage as well as the uncertainties in dosage, timing, safety, and side effects. There are many unknowns regarding pharmacokinetics and pharmacodynamics, particularly bioavailability, metabolism, and tissue specificity of NAD+ boosters. Given the lack of long-term safety studies, there is a need for more clinical trials to determine the proper dose of NAD+ boosters and treatment duration for aging prevention and as disease therapy. Further research will also need to address the long-term consequences of increased NAD+ and the best approaches and combinations to increase NAD+ levels. The answers to the above questions will contribute to the more efficient and safer use of NAD+ boosters. MDPI 2022-08-24 /pmc/articles/PMC9495723/ /pubmed/36139711 http://dx.doi.org/10.3390/antiox11091637 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Poljšak, Borut
Kovač, Vito
Milisav, Irina
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title_full Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title_fullStr Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title_full_unstemmed Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title_short Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
title_sort current uncertainties and future challenges regarding nad+ boosting strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495723/
https://www.ncbi.nlm.nih.gov/pubmed/36139711
http://dx.doi.org/10.3390/antiox11091637
work_keys_str_mv AT poljsakborut currentuncertaintiesandfuturechallengesregardingnadboostingstrategies
AT kovacvito currentuncertaintiesandfuturechallengesregardingnadboostingstrategies
AT milisavirina currentuncertaintiesandfuturechallengesregardingnadboostingstrategies